Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 28;107(7):535-541.
doi: 10.1136/heartjnl-2020-317915. Online ahead of print.

Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China

Xin Du  1   2   3 , Lizhu Guo  1 , Shijun Xia  1 , Jing Du  4 , Craig Anderson  2   3   5   6 , Hisatomi Arima  7 , Mark Huffman  8 , Yiqiang Yuan  9 , Yang Zheng  10 , Shulin Wu  11 , Xuefeng Guang  12 , Xianhui Zhou  13 , Hongbo Lin  14 , Xiaoshu Cheng  15 , Jianzeng Dong  1   16 , Changsheng Ma  17
Affiliations

Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China

Xin Du et al. Heart. .

Abstract

Objective: To determine AF prevalence and gaps in atrial fibrillation (AF) awareness and management in China.

Methods: We conducted a community-based survey of 47 841 adults (age ≥45 years) in seven geographic regions of China between 2014 and 2016. Participants underwent a structured questionnaire, a standard 12-lead ECG, physical examination and blood sampling. AF prevalence, defined by either ECG detection or self-report, was estimated according to sampling weights, non-response and age and sex distribution of the population. We used multivariable logistic regression to estimate associations among sociodemographic, clinical and geographic factors with the AF prevalence, awareness and treatment.

Results: The weighted AF prevalence was 1.8% (95% CI 1.7% to 1.9%), but varied from 0.9% to 2.4% across geographical regions and equates to being present in an estimated 7.9 (95% CI 7.4 to 8.4) million people in China. Among men and women, the AF prevalence increased from 0.8% and 0.6% in the age group 45-54 years to 5.4% and 4.9% in the age group ≥75 years, respectively. Proportions of people who were aware of having AF decreased overall from 65.3% in 45-54 year-olds to 53.9% in ≥75 year-olds and varied between sex (men 58.5%, women 68.8%) and residency status (urban 78.3%, rural 35.3%). Only 6.0% of patients with high-risk AF received anticoagulation therapy.

Conclusions: AF prevalence is higher than previously reported in China, with low awareness and large treatment gaps. Large-scale efforts are urgently needed to reduce AF adverse consequences.

Keywords: atrial fibrillation; epidemiology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CM has received honoraria for presentations from AstraZeneca, Bayer Healthcare, Boehringer Ingelheim, Bristol-Myers Squibb, Johnson & Johnson and Pfizer. JDo has received honoraria for presentations from Johnson & Johnson. CA received grants from the National Health and Medical Research Council of Australia and Takeda and advisory board feeds from Amgen and Boehringer Ingelheim. HA received honoraria for presentations from Bayer, Daiichi Sankyo, MSD, Takeda, Teijin, and fees for consultancy from Kyowa Kirin. MH received grant from the World Heart Federation for the Emerging Leaders program, supported by grants from Boehringer Ingelheim and Novartis with previous support from AstraZeneca and Bupa. MH also received support from the American Heart Association, Verily and AstraZeneca and the American Medical Association for work unrelated to this project.

Figures

Figure 1
Figure 1
Weighted prevalence of prevalent atrial fibrillation in men and women, stratified by age. Bars represent proportions and error bars represent 95% CI.
Figure 2
Figure 2
Weighted prevalence of prevalent atrial fibrillation (A) and ECG-detected atrial fibrillation (B) in men and women, stratified by residence. Bars represent proportions and error bars represent 95% CI.
Figure 3
Figure 3
Awareness of atrial fibrillation by age (A), sex (B) and residency (C). Bars represent proportions.
See this image and copyright information in PMC

References

    1. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 2014;129:837–47. 10.1161/CIRCULATIONAHA.113.005119 - DOI - PMC - PubMed
    1. Kornej J, Börschel CS, Benjamin EJ, et al. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res 2020;127:4–20. 10.1161/CIRCRESAHA.120.316340 - DOI - PMC - PubMed
    1. Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol 2008;18:209–16. 10.2188/jea.JE2008021 - DOI - PMC - PubMed
    1. Coppens M, Eikelboom JW, Hart RG, et al. The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J 2013;34:170–6. 10.1093/eurheartj/ehs314 - DOI - PubMed
    1. Deng H, Guo P, Zheng M, et al. Epidemiological characteristics of atrial fibrillation in southern China: results from the Guangzhou heart study. Sci Rep 2018;8:17829. 10.1038/s41598-018-35928-w - DOI - PMC - PubMed